Cargando…
Hypertonic saline, not mannitol, should be considered gold-standard medical therapy for intracranial hypertension
Hyperosmolar therapy is the principal medical management strategy for elevated intracranial pressure. Mannitol has been the primary hyperosmolar agent for nearly a century and remains the de facto gold standard for medical management of intracranial hypertension. Over the past 25 years, however, hyp...
Autor principal: | Marko, Nicholas F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396262/ https://www.ncbi.nlm.nih.gov/pubmed/22353146 http://dx.doi.org/10.1186/cc11182 |
Ejemplares similares
-
Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury
por: Huang, Xuecai, et al.
Publicado: (2020) -
Effect of osmotherapy with mannitol or hypertonic saline on cerebral oxygenation and metabolism in patients with intracranial hypertension after severe brain injury
por: Suys, T, et al.
Publicado: (2015) -
Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury: Erratum
Publicado: (2021) -
Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on electrolyte and acid‐base variables in dogs with suspected intracranial hypertension
por: Hoehne, Sabrina N., et al.
Publicado: (2020) -
Role of hypertonic saline and mannitol in the management of raised intracranial pressure in children: A randomized comparative study
por: Upadhyay, Piyush, et al.
Publicado: (2010)